Table NPS1: Drug-related deaths on the basis of the Office for National Statistics (ONS) 'wide' definition which involved New Psychoactive Substances (NPSs) 1, 2013

(i) Deaths for which one or more NPSs was implicated in, or potentially contributed to, the death
	Type(s) of NPS that were present
	Benzodiaz-'epine-type NPS present; no other types of NPS	Other types of NPS present; no Benzodiaz-epine-type NPS	Both benzo-diazepine-type NPS and other types of NPS	All type(s) of NPS
Included in this report's statistics²
NPS the only substance(s)* implicated in the death	0	3	0	3
Other substance(s)** implicated in the death	39	13	2	54
All	39	16	2	57
NOT included in this report's statistics
NPS the only substance(s)* implicated in the death	0	2	0	2
Other substance(s)** implicated in the death	0	1	0	1
All	0	3	0	3
All deaths for which one or more NPSs was implicated in, or potentially contributed to, the death
NPS the only substance(s)* implicated in the death	0	5	0	5
Other substance(s)** implicated in the death	39	14	2	55
All	39	19	2	60

	Age at Death					All	Sex
	under 25	25 to 34	35 to 44	45 to 54	55 & over	All	Male	Female
Included in this report's statistics²
Benzodiazepine-type NPS present; no other types of NPS	3	12	15	9	0	39	30	9
Other types of NPS present; no Benzodiazepine-type NPS	6	5	3	2	0	16	12	4
Both Benzodiazepine-type NPS and other types of NPS present	1	1	0	0	0	2	2	0
All	10	18	18	11	0	57	44	13
NOT included in this report's statistics
Benzodiazepine-type NPS present; no other types of NPS	0	0	0	0	0	0	0	0
Other types of NPS present; no Benzodiazepine-type NPS	0	2	0	0	1	3	2	1
Both Benzodiazepine-type NPS and other types of NPS present	0	0	0	0	0	0	0	0
All	0	2	0	0	1	3	2	1
All deaths for which one or more NPSs was implicated in, or potentially contributed to, the death
Benzodiazepine-type NPS present; no other types of NPS	3	12	15	9	0	39	30	9
Other types of NPS present; no Benzodiazepine-type NPS	6	7	3	2	1	19	14	5
Both Benzodiazepine-type NPS and other types of NPS present	1	1	0	0	0	2	2	0
All	10	20	18	11	1	60	46	14

(ii) Deaths for which NPSs were present but were NOT considered to have contributed to the death
	Age at Death					All	Sex
	under 25	25 to 34	35 to 44	45 to 54	55 & over	All	Male	Female
Included in this report's statistics²
Benzodiazepine-type NPS present; no other types of NPS	1	15	21	8	5	50	40	10
Other types of NPS present; no Benzodiazepine-type NPS	0	2	0	0	0	2	2	0
Both Benzodiazepine-type NPS and other types of NPS present	0	0	0	0	0	0	0	0
All	1	17	21	8	5	52	42	10
NOT included in this report's statistics
Benzodiazepine-type NPS present; no other types of NPS	0	0	0	1	0	1	1	0
Other types of NPS present; no Benzodiazepine-type NPS	0	0	0	0	0	0	0	0
Both Benzodiazepine-type NPS and other types of NPS present	0	0	0	0	0	0	0	0
All	0	0	0	1	0	1	1	0
All deaths for which NPSs were present but were not considered to have contributed to the death
Benzodiazepine-type NPS present; no other types of NPS	1	15	21	9	5	51	41	10
Other types of NPS present; no Benzodiazepine-type NPS	0	2	0	0	0	2	2	0
Both Benzodiazepine-type NPS and other types of NPS present	0	0	0	0	0	0	0	0
All	1	17	21	9	5	53	43	10

Footnotes:

The substances which are counted (for the purpose of these figures) as New Psychoactive Substances are described in Annex E.
i.e. within the Drug Strategy 'baseline' definition, as implemented by National Records of Scotland

* apart, perhaps, from alcohol. For example, a death for which mephedrone and alcohol were the only substances that were implicated in the death would be counted under 'NPS the only substance(s) implicated in the death'.

** apart, perhaps, from alcohol.